Quality of Life Among Japanese Oral Contraceptive Users

  • Y. Matsumoto
  • S. Yamabe
  • K. Ideta
Reference work entry


It is difficult to judge the well-being in sexual and reproductive health as it is very subjective matter. QOL is a possible indicator to measure sexual and reproductive health.  Oral contraceptives (OC) can contribute greatly to a woman’s well being by providing a choice of family planning and also as a tool to improve menstruation and hormonal-dependent symptoms such as  dysmenorrhea, irregular menstrual cycles,  menorrhagia,  premenstrual syndrome (PMS), and acne. WHO has developed an assessment instrument for QOL, which has proven systematically relevance in cross-cultural research. WHOQOL-Bref is comprised of 5 domains; physical health, psychological, social relationships, environment, and overall. We performed a questionnaire study to measure QOL among Japanese OC users. QOL measurement using WHOQOL-Bref showed the effectiveness of OC in providing side benefits, however, OC can worsen the QOL of users if it is taken only for contraceptive purpose. Studies have proven that women are more satisfied with permanent contraceptive methods such as vasectomy and tubal ligation than nonpermanent methods such as intrauterine device, injection, and OC. However, compliance has improved among OC users after counseling. Information, education, and counseling before staring OC will improve the practice of family planning and promote QOL among OC users.


Oral Contraceptive Reproductive Health Sexual Health Contraceptive Method Sexually Transmit Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

List of Abbreviations:


derogatis sexual functioning inventory


international conference on population and development


oral contraceptives


premenstrual syndrome


sexually transmitted diseases


World Health Organization quality of life


  1. Cogliano V, Grosse Y, Baan R, Straif K, Secretan B, Ghissassi FE, WHO International Agency for Research on Cancer. (2005). Lancet Oncol. 6(8): 552–553.PubMedCrossRefGoogle Scholar
  2. Davis AR, Westhoff C, O’Connell K, Gallagher N. (2005). Obstet Gynecol. 106: 97–104.PubMedCrossRefGoogle Scholar
  3. Derogatis LR. (2008). Int J Impot Res. 20(1): 35–44.PubMedCrossRefGoogle Scholar
  4. Fraser IS, McCarron G. (1991). J Obstet Gynaecol. 31: 66–70.Google Scholar
  5. Gaudet LM, Kives S, Hahn PM, Reid RL. (2004). Contraception. 69(1): 31–36.PubMedCrossRefGoogle Scholar
  6. Gupta S. (2000). Hum Reprod Update. 6(5): 427–431.PubMedCrossRefGoogle Scholar
  7. Guyatt GH, Cook DJ. (1994). JAMA. 272(8): 630–631.PubMedCrossRefGoogle Scholar
  8. Joffe H, Cohen LS, Harlow BL. (2003). Am J Obstet Gynecol. 189: 1523–1530.PubMedCrossRefGoogle Scholar
  9. Li RHW, Lo SST, Teh DKG, Tong NC, Tsui MHY, Cheung KB, Chung TKH. (2004). Contraception. 70: 474–482.PubMedCrossRefGoogle Scholar
  10. Matsumoto Y, Yamabe S, Asahara S, Yokota H, Mandai K, Ideta K. (2006). Adv Obstet Gynecol. 58(2): 130–135.Google Scholar
  11. Matsumoto Y, Yamabe S, Ideta K, Kawabata M. (2007). J Obstet Gynaecol Res. 33(4): 529–535.PubMedCrossRefGoogle Scholar
  12. Miller AM. (2000). Health Hum Rights. 4(2): 68–109.PubMedCrossRefGoogle Scholar
  13. Oddens BJ. (1999). Contraception. 59: 277–286.PubMedCrossRefGoogle Scholar
  14. Redmond G, Godwin AJ, Olson W, Lippman JS. (1999). Contraception. 60(2): 81–85.PubMedCrossRefGoogle Scholar
  15. Robinson SA, Dowell M, Pedulla D, Mc Cauley. (2004). Med Hypotheses. 63(2): 268–273.PubMedCrossRefGoogle Scholar
  16. Rosen MP, Breitkopf DM, Nagamani M. (2003). Am J Obstet Gynecol. 188: 1158–1160.PubMedCrossRefGoogle Scholar
  17. Rosenberg MJ, Waugh MS. (1998). Am J Obstet Gynecol. 179: 577–582.PubMedCrossRefGoogle Scholar
  18. Rosenfield JA, Zahorik PM, Saint W, Murphy G. (1993). J Fam Pract. 36: 169–173.Google Scholar
  19. Sanders SA, Graham CA, Bass JL, Bancroft J. (2001). Contraception. 64(1): 51–58.PubMedCrossRefGoogle Scholar
  20. Saxena S, Carlson D, Billington R. (2001). Qual Life Res. 10(8): 711–721.PubMedCrossRefGoogle Scholar
  21. Speroff L, Fritz MA. (2005). Oral contraception: Clinical gynecologic endocrinology and infertility, 7th ed. Lippincott Williams & Wilkins, Philadelphia, pp. 862–942.Google Scholar
  22. Sullivan F, Wyatt JC. (2005). BMJ. 331: 625–627.PubMedCrossRefGoogle Scholar
  23. The Practice Committee of the American Society for Reproductive Medicine. (2004). Fertil Steril. 82: 266–272.CrossRefGoogle Scholar
  24. UNFPA: ICPD & MDG Follow up; Summary of the ICPD Programme of Action (Accessed on January 5, 2008).
  25. United Nations Population Division Department of Economics and Social Affairs World Contraceptive Use. (2005). (Accessed on January 5, 2008).
  26. Urdl W, Apter D, Alperstein A, Koll P, Schönian S, Bringer J, Fisher AC, Preik M. (2005). Eur J Obstet Gynecol Reprod Biol. 121(2): 202–210.PubMedCrossRefGoogle Scholar
  27. van de Weijer P. (2005). Eur J Contracept Reprod Health Care. 10 Suppl 1: 2–6.PubMedCrossRefGoogle Scholar
  28. Vessey M, Painter R. (2006). Br J Cancer. 95(3): 385–389.PubMedCrossRefGoogle Scholar
  29. World Health Organization. (2004). Medical eligibility criteria for contraceptive use (Accessed on January 5, 2008).

Copyright information

© Springer Science+Business Media LLC 2010

Authors and Affiliations

  • Y. Matsumoto
    • 1
  • S. Yamabe
    • 1
  • K. Ideta
    • 1
  1. 1.Department of International CooperationYodogawa Christian HospitalOsakaJapan

Personalised recommendations